These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8977155)

  • 41. Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population. The Sardinian Diabetes Genetic Study Group.
    Tonolo G; Melis MG; Ciccarese M; Secchi G; Atzeni MM; Maioli M; Pala G; Massidda A; Manai M; Pilosu RM; Li LS; Luthman H; Maioli M
    Diabetologia; 1997 Jan; 40(1):89-94. PubMed ID: 9028723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence to support a spectrum of active states for the glucagon receptor.
    Strudwick N; Bhogal N; Evans NA; Blaney FE; Findlay JB
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1037-9. PubMed ID: 15506957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone action.
    Day JW; Li P; Patterson JT; Chabenne J; Chabenne MD; Gelfanov VM; Dimarchi RD
    J Pept Sci; 2011 Mar; 17(3):218-25. PubMed ID: 21308878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal lithium clearance in the different stages of hypertension.
    Niutta E; Barlassina C; Colombo R; Dossi F; Pellizzoni M; Cusi DM; Cesana B; Bianchi G
    J Hypertens; 1991 Dec; 9(12):1135-42. PubMed ID: 1663969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of key residues for the binding of glucagon to the N-terminal domain of its receptor: an alanine scan and modeling study.
    Prévost M; Vertongen P; Waelbroeck M
    Horm Metab Res; 2012 Oct; 44(11):804-9. PubMed ID: 22893257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A young renal transplant recipient with unexplained resting sinus tachycardia, hypertension and beta-blocker resistance.
    Fehr T; Zimmermann DR; Wüthrich RP; Ammann P
    Nephrol Dial Transplant; 2004 Jun; 19(6):1646-9. PubMed ID: 15150364
    [No Abstract]   [Full Text] [Related]  

  • 47. Human glucagon receptor monoclonal antibodies: antagonism of glucagon action and use in receptor characterization.
    Buggy J; Rossomando A; MacDougall M; Mierz D; Wunderlich D; Yoo-Warren H
    Horm Metab Res; 1996 May; 28(5):215-9. PubMed ID: 8738108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function.
    Van Eyll B; Göke B; Wilmen A; Göke R
    Peptides; 1996; 17(4):565-70. PubMed ID: 8804062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of glucagon receptors in tetracycline-inducible HEK293S GnT1- stable cell lines: an approach toward purification of receptor protein for structural studies.
    Unson CG
    Biopolymers; 2008; 90(3):287-96. PubMed ID: 18260137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and characterization of a glucagon receptor from the goldfish Carassius auratus: implications for the evolution of the ligand specificity of glucagon receptors in vertebrates.
    Chow BK; Moon TW; Hoo RL; Yeung CM; Müller M; Christos PJ; Mojsov S
    Endocrinology; 2004 Jul; 145(7):3273-88. PubMed ID: 15033912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucagon cell adenomatosis without glucagon receptor mutation.
    Al-Sarireh B; Haidermota M; Verbeke C; Rees DA; Yu R; Griffiths AP
    Pancreas; 2013 Mar; 42(2):360-2. PubMed ID: 23407487
    [No Abstract]   [Full Text] [Related]  

  • 52. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
    Heller RS; Kieffer TJ; Habener JF
    Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: a case control study.
    Say YH; Ling KH; Duraisamy G; Isaac S; Rosli R
    BMC Cardiovasc Disord; 2005 Apr; 5(1):7. PubMed ID: 15811183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
    Al-Sabah S; Donnelly D
    Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor.
    Jeanneteau F; Funalot B; Jankovic J; Deng H; Lagarde JP; Lucotte G; Sokoloff P
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10753-8. PubMed ID: 16809426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity.
    Wilmen A; Göke B; Göke R
    FEBS Lett; 1996 Nov; 398(1):43-7. PubMed ID: 8946950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.
    Yahalom G; Kaplan N; Vituri A; Cohen OS; Inzelberg R; Kozlova E; Korczyn AD; Rosset S; Friedman E; Hassin-Baer S
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1039-41. PubMed ID: 22703868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substitution of aspartic acid for glycine at position 310 in type II collagen produces achondrogenesis II, and substitution of serine at position 805 produces hypochondrogenesis: analysis of genotype-phenotype relationships.
    Bonaventure J; Cohen-Solal L; Ritvaniemi P; Van Maldergem L; Kadhom N; Delezoide AL; Maroteaux P; Prockop DJ; Ala-Kokko L
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):823-30. PubMed ID: 7741714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.
    Dessì-Fulgheri P; Sarzani R; Tamburrini P; Moraca A; Espinosa E; Cola G; Giantomassi L; Rappelli A
    J Hypertens; 1997 Dec; 15(12 Pt 2):1695-9. PubMed ID: 9488224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of the LRRK2 G2019S mutation in Alzheimer Disease.
    Zabetian CP; Lauricella CJ; Tsuang DW; Leverenz JB; Schellenberg GD; Payami H
    Arch Neurol; 2006 Jan; 63(1):156-7. PubMed ID: 16401756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.